Últimas noticias sobre Robinhood Markets (NASDAQ:HOOD) Bolsa

Robinhood Markets

Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fractional shares, recurring investments, and IPO Access. It earns transaction-based revenues from routing user orders for options, equities, and cryptocurrencies to market makers when a routed order is executed.

Equities

News

Markets

ETFs

ACCD

ARKW

ESLT

HOOD

Ark Invest vende acciones de Robinhood en medio de desafíos económicos y oportunidades regulatorias. Descubre las claves de este movimiento.

Ark Invest vende acciones de Robinhood (HOOD): Impacto en el mercado y ajustes clave del portafolio

Tech

General

ADPV

Robinhood enfrenta multas de la SEC por incumplimientos normativos, pero HOOD aumenta. ¿Qué esperar en 2025 según los analistas?

Robinhood aumenta a pesar de multas por $45M

Las acciones de Robinhood caen tras datos que revelan un enfriamiento del mercado laboral en EE.UU., afectando a los inversores minoristas.

Robinhood enfrenta caídas en sus acciones tras enfriamiento del mercado laboral

Robinhood Markets, Inc. - Class A Common Stock

Robinhood Markets Inc

WIIM

SWKS

Skyworks shares are trading lower after the company issued Q2 adjusted EPS guidance below estimates.

Guidance

McKesson Sees FY25 Adj. EPS $32.55-$32.95 Vs $36.70 Estimate

<p><strong>Rexford Industrial Realty</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REXR#NYSE">REXR</a>) reported its Q4 earnings results on Wednesday, February 5, 2025 at 04:08 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Rexford Industrial Realty missed estimated earnings by 0.0%, reporting an EPS of $0.58 versus an estimate of $0.58.</p>
<p>Revenue was up $31.83 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>Last quarter the company beat on EPS by $0.01 which was followed by a 9.0% drop in the share price the next day.</p>
<p>Here's a look at Rexford Industrial Realty's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.58</td>
<td>0.58</td>
<td>0.57</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.59</td>
<td>0.60</td>
<td>0.58</td>
<td>0.56</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>239.70M</td>
<td>227.67M</td>
<td>211.56M</td>
<td>201.88M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>238.40M</td>
<td>232.97M</td>
<td>210.99M</td>
<td>207.91M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Rexford Industrial Realty management provided guidance for FY 2025, expecting earnings between $2.37 and $2.41 per share.</p>
<p>To track all earnings releases for Rexford Industrial Realty <a href="https://www.benzinga.com/quote/REXR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

REXR

Insights into Rexford Industrial Realty Q4 Earnings

<p><strong>CSG Systems Intl</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGS#NASDAQ">CSGS</a>) announced its Q4 earnings on Wednesday, February 5, 2025 at 04:00 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>CSG Systems Intl beat estimated earnings by 36.0%, reporting an EPS of $1.65 versus an estimate of $1.21.</p>
<p>Revenue was up $19.33 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>During the previous quarter, the company missed on EPS by $0.0, leading to a 9.0% increase share price change the next day.</p>
<p>Here's a look at CSG Systems Intl's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.06</td>
<td>0.91</td>
<td>0.93</td>
<td>0.86</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.06</td>
<td>1.02</td>
<td>1.01</td>
<td>0.92</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>296.24M</td>
<td>273.76M</td>
<td>284.17M</td>
<td>281.16M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>295.14M</td>
<td>290.32M</td>
<td>295.13M</td>
<td>297.32M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>CSG Systems Intl management provided guidance for FY 2025, expecting earnings between $4.55 and $4.8 per share.</p>
<p>To track all earnings releases for CSG Systems Intl <a href="https://www.benzinga.com/quote/CSGS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CSGS

CSG Systems Intl Earnings Report: Q4 Overview

<p><strong>Amtech Systems</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASYS#NASDAQ">ASYS</a>) reported its Q1 earnings results on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Amtech Systems beat estimated earnings by 0.06%, reporting an EPS of $0.06 versus an estimate of $0.0.</p>
<p>Revenue was down $535 thousand from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>In the previous quarter, the company missed on EPS by $0.01, resulting in a 8.0% drop change in the share price the following day.</p>
<p>Here's a look at Amtech Systems's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.01</td>
<td>-0.06</td>
<td>-0.13</td>
<td>-0.26</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0</td>
<td>0.08</td>
<td>-0.01</td>
<td>-0.04</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>23.75M</td>
<td>24.15M</td>
<td>23.50M</td>
<td>22.25M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>24.11M</td>
<td>26.75M</td>
<td>25.43M</td>
<td>24.92M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Amtech Systems <a href="https://www.benzinga.com/quote/ASYS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ASYS

Amtech Systems Q1 Earnings Summary & Key Takeaways

<p>The Q4 earnings report for <strong>Corpay</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) was released on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Corpay beat estimated earnings by 0.0%, reporting an EPS of $5.36 versus an estimate of $5.35.</p>
<p>Revenue was up $96.68 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company beat on EPS by $0.03 in the last quarter, resulting in a 6.0% increase share price change the following day.</p>
<p>Here's a look at Corpay's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>4.97</td>
<td>4.50</td>
<td>4.1</td>
<td>4.48</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>5</td>
<td>4.55</td>
<td>4.1</td>
<td>4.44</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.03B</td>
<td>972.73M</td>
<td>938.02M</td>
<td>970.15M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.03B</td>
<td>975.71M</td>
<td>935.25M</td>
<td>937.32M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Corpay management provided guidance for Q1 2025, expecting earnings between $4.45 and $4.55 per share.</p>
<p>To track all earnings releases for Corpay <a href="https://www.benzinga.com/quote/CPAY/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CPAY

Corpay: Q4 Earnings Insights

<p><strong>Blue Bird</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>) just disclosed its Q1 earnings on Wednesday, February 5, 2025 at 04:00 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Blue Bird beat estimated earnings by 14.000000000000002%, reporting an EPS of $0.92 versus an estimate of $0.81.</p>
<p>Revenue was down $3.79 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.15 in the last quarter, resulting in a 5.0% drop share price change the following day.</p>
<p>Here's a look at Blue Bird's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.92</td>
<td>0.51</td>
<td>0.48</td>
<td>0.37</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.77</td>
<td>0.91</td>
<td>0.89</td>
<td>0.91</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>346.59M</td>
<td>328.60M</td>
<td>298.41M</td>
<td>275.13M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>350.21M</td>
<td>333.37M</td>
<td>345.92M</td>
<td>317.66M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Blue Bird <a href="https://www.benzinga.com/quote/BLBD/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BLBD

Blue Bird: Q1 Earnings Insights

Management

INSG

Inseego Appoints Jeff Tuder As Chairman; Succeeds Phil Brace

<p><strong>Conmed</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) just disclosed its Q4 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Conmed beat estimated earnings by 12.0%, reporting an EPS of $1.34 versus an estimate of $1.2.</p>
<p>Revenue was up $18.90 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.06 in the last quarter, resulting in a 5.0% increase share price change the following day.</p>
<p>Here's a look at Conmed's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.99</td>
<td>0.91</td>
<td>0.74</td>
<td>1.11</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.05</td>
<td>0.98</td>
<td>0.79</td>
<td>1.06</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>318.13M</td>
<td>332.32M</td>
<td>306.78M</td>
<td>332.20M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>316.70M</td>
<td>332.10M</td>
<td>312.27M</td>
<td>327.05M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Conmed management provided guidance for FY 2025, expecting earnings between $4.25 and $4.4 per share.</p>
<p>To track all earnings releases for Conmed <a href="https://www.benzinga.com/quote/CNMD/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CNMD

Conmed Q4 Earnings Summary & Key Takeaways

<p>Itau Unibanco Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITUB#NYSE">ITUB</a>) reported quarterly earnings of $0.19 per share which met the analyst consensus estimate. This is unchanged from the same period last year.  The company reported quarterly sales of $7.56 billion which missed the analyst consensus estimate of $7.61 billion by 0.57 percent.  This is a 8.58 percent decrease over sales of $8.27 billion the same period last year.</p>


Earnings Misses

ITUB

Itau Unibanco Holding Q4 2024 GAAP EPS $0.19, Inline, Sales $7.56B Miss $7.61B Estimate

<p><strong>Qiagen</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QGEN#NYSE">QGEN</a>) reported its Q4 earnings results on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Qiagen missed estimated earnings by -2.0%, reporting an EPS of $0.61 versus an estimate of $0.62.</p>
<p>Revenue was up $11.84 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>Last quarter the company beat on EPS by $0.03 which was followed by a 1.0% increase in the share price the next day.</p>
<p>Here's a look at Qiagen's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.54</td>
<td>0.51</td>
<td>0.44</td>
<td>0.53</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.57</td>
<td>0.55</td>
<td>0.46</td>
<td>0.55</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>491.75M</td>
<td>494.49M</td>
<td>457.33M</td>
<td>501.28M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>502.00M</td>
<td>496.00M</td>
<td>458.80M</td>
<td>509.16M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Qiagen <a href="https://www.benzinga.com/quote/QGEN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


QGEN

Qiagen Q4 Earnings Report: What Investors Need to Know

<p>The earnings results for <strong>Omega Healthcare Invts</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OHI#NYSE">OHI</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Omega Healthcare Invts beat estimated earnings by 1.0%, reporting an EPS of $0.74 versus an estimate of $0.73.</p>
<p>Revenue was up $40.00 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>In the previous quarter, the company beat on EPS by $0.03, resulting in a 0.0% increase change in the share price the following day.</p>
<p>Here's a look at Omega Healthcare Invts's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.71</td>
<td>0.68</td>
<td>0.65</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.74</td>
<td>0.71</td>
<td>0.68</td>
<td>0.68</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>261.64M</td>
<td>246.73M</td>
<td>231.64M</td>
<td>233.82M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>276.03M</td>
<td>252.75M</td>
<td>243.30M</td>
<td>239.32M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Omega Healthcare Invts management provided guidance for FY 2025, expecting earnings between $2.9 and $2.98 per share.</p>
<p>To track all earnings releases for Omega Healthcare Invts <a href="https://www.benzinga.com/quote/OHI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Omega Healthcare Invts Q4 Earnings Assessment

CTVA

Corteva shares are trading lower after the company reported worse-than-expected Q4 sales results.

<p>The Q3 earnings report for <strong>ePlus</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUS#NASDAQ">PLUS</a>) was released on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>ePlus missed estimated earnings by -13.0%, reporting an EPS of $1.06 versus an estimate of $1.22.</p>
<p>Revenue was up $1.91 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.03 in the previous quarter, leading to a 16.0% drop share price change the next day.</p>
<p>Here's a look at ePlus's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.39</td>
<td>1.17</td>
<td>1.17</td>
<td>1.38</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.36</td>
<td>1.13</td>
<td>0.93</td>
<td>1.18</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>576.50M</td>
<td>555.23M</td>
<td>537.83M</td>
<td>595.07M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>515.17M</td>
<td>544.54M</td>
<td>554.46M</td>
<td>509.06M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for ePlus <a href="https://www.benzinga.com/quote/PLUS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


PLUS

ePlus Earnings Report: Q3 Overview

<p>The earnings results for <strong>Equitable Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Equitable Hldgs missed estimated earnings by -3.0%, reporting an EPS of $1.57 versus an estimate of $1.62.</p>
<p>Revenue was up $1.45 billion from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>During the previous quarter, the company missed on EPS by $0.0, leading to a 1.0% drop share price change the next day.</p>
<p>Here's a look at Equitable Hldgs's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.53</td>
<td>1.40</td>
<td>1.33</td>
<td>1.20</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.53</td>
<td>1.43</td>
<td>1.43</td>
<td>1.33</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>3.86B</td>
<td>3.81B</td>
<td>3.72B</td>
<td>3.54B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>3.08B</td>
<td>3.51B</td>
<td>2.23B</td>
<td>2.17B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Equitable Hldgs <a href="https://www.benzinga.com/quote/EQH/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Equitable Hldgs Q4 Earnings Assessment

<p>The earnings results for <strong>Black Hills</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKH#NYSE">BKH</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Black Hills beat estimated earnings by 2.0%, reporting an EPS of $1.37 versus an estimate of $1.34.</p>
<p>Revenue was up $5.40 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>The company missed on EPS by $0.17 in the last quarter, resulting in a 1.0% drop share price change the following day.</p>
<p>Here's a look at Black Hills's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.52</td>
<td>0.25</td>
<td>1.70</td>
<td>1.08</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.35</td>
<td>0.33</td>
<td>1.87</td>
<td>1.17</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>446.19M</td>
<td>510.60M</td>
<td>683.04M</td>
<td>863.66M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>401.60M</td>
<td>402.60M</td>
<td>726.40M</td>
<td>591.70M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Black Hills management provided guidance for FY 2025, expecting earnings between $4.0 and $4.2 per share.</p>
<p>To track all earnings releases for Black Hills <a href="https://www.benzinga.com/quote/BKH/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Black Hills Earnings Review: Q4 Summary

<p>The Q4 earnings report for <strong>UDR</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UDR#NYSE">UDR</a>) was released on Wednesday, February 5, 2025 at 04:16 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>UDR missed estimated earnings by 0.0%, reporting an EPS of $0.63 versus an estimate of $0.63.</p>
<p>Revenue was up $9.55 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous quarter, the company missed on EPS by $0.0, resulting in a 3.0% drop change in the share price the following day.</p>
<p>Here's a look at UDR's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.62</td>
<td>0.61</td>
<td>0.61</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.62</td>
<td>0.62</td>
<td>0.61</td>
<td>0.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>416.51M</td>
<td>414.11M</td>
<td>408.61M</td>
<td>410.19M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>418.09M</td>
<td>413.33M</td>
<td>411.67M</td>
<td>410.89M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>UDR management provided guidance for FY 2025, expecting earnings between $2.45 and $2.55 per share.</p>
<p>To track all earnings releases for UDR <a href="https://www.benzinga.com/quote/UDR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


UDR Earnings Review: Q4 Summary

<p><strong>Lesaka Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSAK#NASDAQ">LSAK</a>) just disclosed its Q2 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Lesaka Technologies missed estimated earnings by 0.0%, reporting an EPS of $0.01 versus an estimate of $0.01.</p>
<p>Revenue was up $2.92 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>In the previous quarter, the company beat on EPS by $0.08, resulting in a 3.0% drop change in the share price the following day.</p>
<p>Here's a look at Lesaka Technologies's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.04</td>
<td>-0.06</td>
<td>-0.04</td>
<td>-0.03</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.04</td>
<td>0.02</td>
<td>0.02</td>
<td>0.01</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>144.16M</td>
<td>149.30M</td>
<td>145.53M</td>
<td>144.47M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>145.55M</td>
<td>146.05M</td>
<td>138.19M</td>
<td>143.89M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Lesaka Technologies <a href="https://www.benzinga.com/quote/LSAK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


LSAK

Lesaka Technologies Q2 Earnings Assessment

Earnings Beats

Becton, Dickinson Q1 2025 Adj. EPS $3.43 Beats $2.98 Estimate, Sales $5.168B Beat $5.100B Estimate

<p>Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $1.02 by 58.82 percent. This is a 92.86 percent increase over earnings of $0.84 per share from the same period last year.  The company reported quarterly sales of $409.00 million which missed the analyst consensus estimate of $418.33 million by 2.23 percent.  This is a 1.51 percent increase over sales of $402.90 million the same period last year.</p>


Horace Mann Educators Q4 Adj $1.62 Beats $1.02 Estimate, Sales $409.00M Miss $418.33M Estimate

There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Robinhood Markets (HOOD – Research Report) and Veris...

Analysts Offer Insights on Technology Companies: Robinhood Markets (HOOD) and Verisign (VRSN)

There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Harmonic (HLIT – Research Report) and Robinhood Mark...

Analysts Are Bullish on These Technology Stocks: Harmonic (HLIT), Robinhood Markets (HOOD)

The Commodity Futures Trading Commission has formally requested that Robinhood (HOOD) Derivatives "not permit customers to access" sports event con...

Robinhood suspends Football Championship market after CFTC request

Robinhood suspends Super Bowl betting contracts after CFTC request

Wall Street Lunch: It's No Yolk - Egg Surcharges Are Here

Raymond James analyst Patrick O'Shaughnessy initiated coverage of Robinhood (HOOD) with a Market Perform rating and no price target Robinhood has b...

Robinhood initiated with a Market Perform at Raymond James

Another week another gap down to start. This time, however, the bulls reasserted control of the tape much more quickly than before, and now we see stocks pressing back and onward to new highs.

The Bulls Backed Down The Bears (Again) - Here's What To Do

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2024 Update

Gator Capital Management Q4 2024 Investor Letter

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

AMD, Spotify downgraded: Wall Street's top analyst calls

ACHR

AMZN

ARKB

ARKF

ARKG

ARKK

ARKQ

ARKX

ATEN

AZPN

BEAM

BSQKZ

COIN

COLB

CRSP

CSGP

DKNG

FCNCA

HIFS

HLIT

ILMN

KINS

KSCP

MRNA

MSFT

NTLA

NVDA

NXPI

OPRA

PATH

PLTR

PNFP

RBLX

REGN

ROKU

SHOP

SLAB

SNAP

SPOT

TCBI

TSLA

UMBF

VRSN

Screenshot 2024-12-16 at 6.50.17 PM

Options

CBOE

Interest in Index Options Continue to Grow–Find Out Why

Screenshot 2024-11-15 at 8.03.57 PM

Fintech news covering the emerging Financial Technology services sector

Fintech

Cboe Is Helping Lead The Retail Trading Revolution With A New Robinhood Collaboration

Interview

CEO Of Cboe Sits Down With Benzinga To Talk State Of The Markets

Screenshot 2024-11-08 at 6.43.12 PM

VIX Options Can Help You Navigate All Kinds Of Markets

Screenshot 2024-10-17 at 12.36.52 AM

Active Traders And Investors Could Find Significant Balance Boosts During Robinhood&#39;s Upcoming HOOD Week

Screenshot 2024-09-11 at 5.36.02 PM

Real Estate

AIRE

EXPE

TSX:CSU

With The Effective End Of The 6% Real Estate Commission Standard, reAlpha&#39;s AI-Powered Homebuying Platform Hopes To Shake Up The Industry

Screenshot 2024-08-23 at 5.47.02 PM

Movers & Shakers

ABNB

FRGE

SCHW

UBER

Linqto&#39;s Plan To Bring More Wealth Generation Opportunities To A Generation Of Investors That&#39;s Wary Of Traditional Financial Institutions

Screenshot 2024-08-23 at 5.37.39 PM

Wolfpack Financial Has A Plan To Help Millennials And Gen Z Attain Their American Dream

Screenshot 2024-08-02 at 5.41.43 PM

AAPL

Private Companies Are 50% More Profitable Than Public Companies And Are At Lower Valuations – Now You Can Invest In Them With Linqto

Screenshot 2024-07-26 at 5.39.10 PM

Linqto&#39;s Platform Provides Interested Investors With True Access To Pre-IPO Companies

Press Releases

Robinhood Markets, Inc. Reports November 2024 Operating Data

KBW Announces Index Rebalancing for Fourth-Quarter 2024

Robinhood Markets, Inc. to Announce Fourth Quarter and Full Year 2024 Results on February 12, 2025

Small Cap

Crypto Investments Surge as Global Markets Gear Up for Trump's Inauguration

Robinhood Joins SS&C's RolloverCentral® as IRA Provider

Contracts

CME Group Futures to Launch on Robinhood, Bringing New Trading Opportunities to Retail Investors

Comments

Robinhood Markets

Noticias

Últimas noticias sobre Robinhood Markets (NASDAQ:HOOD) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL